Literature DB >> 19260479

Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell.

Jian Ding1, Dan Li, Xiaozhong Wang, Chengdang Wang, Ting Wu.   

Abstract

BACKGROUND/AIMS: The study was designed to investigate a potential role and mechanisms of fibronectin in tyrosine phosphorylation of focal adhesion kinase (FAK) and invasiveness of colon cancer cells.
METHODOLOGY: A colorectal cancer cell line, Colo320, was stimulated by fibronectin with gradient concentrations. Phosphorylation of FAK tyrosine 397 (tyr-397), was detected by immunoprecipitation and western-blotting. The invasiveness of Colo320 cells was measured by the modified Boyden chamber assay. An antisense oligonucleotide of FAK was used to testify the role of FAK tyr-397 in the process of cell invasion enhanced by fibronectin.
RESULTS: The Colo320 cell showed a dose-independence on fibronectin in its invasion and phosphorylation of FAK tyr-397. Invasion and phosphorylation of FAK tyr-397 in Colo320 reached their climax when concentration of fibronectin reached 1 nmol/L. But they did not increased accordingly when the concentrations of fibronectin reached 10 nmol/L and 100 nmol/L. Antisense oligonucleotide decreased phosphorylation of FAK tyr-397 and the invasion of Colo320 cells significantly, compared with the controls.
CONCLUSIONS: Fibronectin can promote invasion of Colo320 cells, FAK tyrosine phosphorylation plays a key role in this process. Inhibition of FAK expression can inhibit colon cancer cell invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19260479

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

2.  The dual kinase complex FAK-Src as a promising therapeutic target in cancer.

Authors:  Victoria Bolós; Joan Manuel Gasent; Sara López-Tarruella; Enrique Grande
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

3.  Ovarian and Breast Cancer Migration Dynamics on Laminin and Fibronectin Bidirectional Gradient Fibers Fabricated via Multiphoton Excited Photochemistry.

Authors:  Visar Ajeti; Jorge Lara-Santiago; Samuel Alkmin; Paul J Campagnola
Journal:  Cell Mol Bioeng       Date:  2017-07-10       Impact factor: 2.321

4.  Targets of miR-200c mediate suppression of cell motility and anoikis resistance.

Authors:  Erin N Howe; Dawn R Cochrane; Jennifer K Richer
Journal:  Breast Cancer Res       Date:  2011-04-18       Impact factor: 6.466

5.  Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study.

Authors:  Annelies Suetens; Marjan Moreels; Roel Quintens; Sabina Chiriotti; Kevin Tabury; Arlette Michaux; Vincent Grégoire; Sarah Baatout
Journal:  Int J Oncol       Date:  2014-02-03       Impact factor: 5.650

6.  Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation.

Authors:  Annelies Suetens; Marjan Moreels; Roel Quintens; Els Soors; Jasmine Buset; Sabina Chiriotti; Kevin Tabury; Vincent Gregoire; Sarah Baatout
Journal:  J Radiat Res       Date:  2014-09-04       Impact factor: 2.724

7.  Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model.

Authors:  Victoria A Elliott; Piotr Rychahou; Yekaterina Y Zaytseva; B Mark Evers
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

8.  Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.

Authors:  Menglu Li; Kaige Wang; Yanhua Pang; Hongpan Zhang; Hao Peng; Qi Shi; Zhiyu Zhang; Xiaobin Cui; Feng Li
Journal:  Med Sci Monit       Date:  2020-03-24

Review 9.  Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are.

Authors:  Mattia Saggioro; Edoardo D'Angelo; Gianni Bisogno; Marco Agostini; Michela Pozzobon
Journal:  Front Oncol       Date:  2020-03-03       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.